Selected article for: "clinical epidemiology and treatment prevention"
Author: Rehman, Suriya; Majeed, Tariq; Azam Ansari, Mohammad; Ali, Uzma; Sabit, Hussein; Al-Suhaimi, Ebtesam A.
Title: Current Scenario of COVID-19 in Pediatric Age Group and Physiology of Immune and Thymus response
  • Cord-id: 93kxeb50
  • Document date: 2020_5_15
    • ID: 93kxeb50
    Snippet: Abstract COVID-19 pandemic caused by SARS-CoV-2, continues to manifest with severe acute respiratory syndrome among the adults, however, it offers a convincing indication of less severity and fatality in pediatric age group (0-18 years). The current trend suggests that children may get infected but are less symptomatic with less fatality, which is concordant to earlier epidemic outbreaks of SARS-CoV and MERS-CoV, in 2002 and 2012, respectively. According to the available data, children appear to
    Document: Abstract COVID-19 pandemic caused by SARS-CoV-2, continues to manifest with severe acute respiratory syndrome among the adults, however, it offers a convincing indication of less severity and fatality in pediatric age group (0-18 years). The current trend suggests that children may get infected but are less symptomatic with less fatality, which is concordant to earlier epidemic outbreaks of SARS-CoV and MERS-CoV, in 2002 and 2012, respectively. According to the available data, children appear to be at lower risk for COVID-19, as adults constitute for maximum number of the confirmed cases (308,592) and deaths (13,069) as on 22nd March ( https://www.worldometers.info/coronavirus ). However, rapid publications and information of the adult patients with COVID-19 is in progress and published, on the contrary, almost no comprehensive data or discussion about the COVID-19 in children is available. Therefore, in this review, we outline the epidemiology, clinical symptoms, diagnosis, treatment, prevention, possible immune response and role of thymus in children to combat the COVID-19 outbreak.

    Search related documents:
    Co phrase search for related documents
    • activation proliferation and additional activation: 1
    • acute ards respiratory distress syndrome and long period: 1, 2
    • acute ards respiratory distress syndrome and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and lung activate: 1, 2, 3, 4
    • adaptive immune mechanism and long period: 1
    • lopinavir ritonavir and lung activate: 1, 2